PART I . Overview We are a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes. Founded in 2018, atai emerged from the urgent need for better mental health solutions for patients who are under-served by current treatment options. We are advancing a pipeline of product candidates designed to address the complex nature of mental health disorders. We believe that these investigational compounds have the potential t...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-17 | 2024-12-31 | 0000950170-25-040244 | EDGAR | 146K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038138 | EDGAR | — |
| 2023-03-24 | 2022-12-31 | 0000950170-23-009756 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0000950170-22-005013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-277583 | EDGAR | 57K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108883 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071435 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000950170-24-126515 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096296 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060044 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063730 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041345 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021271 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024162 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017253 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0000950170-22-009966 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-05 | 0001140361-25-044579 | EDGAR | 4K words |
| 2025-11-12 | 0001140361-25-041546 | EDGAR | — |
| 2025-11-05 | 0001140361-25-040444 | EDGAR | — |
| 2025-11-05 | 0001140361-25-040429 | EDGAR | — |
| 2025-11-04 | 0001140361-25-040358 | EDGAR | — |
| 2025-10-27 | 0001140361-25-039317 | EDGAR | — |
| 2025-10-21 | 0001140361-25-038748 | EDGAR | — |
| 2025-10-20 | 0001140361-25-038525 | EDGAR | — |
| 2025-10-16 | 0001140361-25-038319 | EDGAR | — |
| 2025-10-10 | 0001140361-25-037941 | EDGAR | — |
99 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001840904 |
| Ticker | ATAI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | P7 |
| Website | https://www.ataibeckley.com |
| Listed | 2021-06-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ATAI (~200 tokens, structured JSON with cryptographic provenance)